These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25925123)

  • 1. Recent developments in skin mimic systems to predict transdermal permeation.
    Waters LJ
    Curr Pharm Des; 2015; 21(20):2725-32. PubMed ID: 25925123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear free energy relationship analysis of permeability across polydimethylsiloxane (PDMS) membranes and comparison with human skin permeation in vitro.
    Liu X; Zhang K; Abraham MH
    Eur J Pharm Sci; 2018 Oct; 123():524-530. PubMed ID: 30107227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Humidity on In Vitro Human Skin Permeation Experiments for Predicting In Vivo Permeability.
    Ishida M; Takeuchi H; Endo H; Yamaguchi JI
    J Pharm Sci; 2015 Dec; 104(12):4223-4231. PubMed ID: 26461468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the skin permeation barrier: challenges and opportunities.
    Vitorino C; Sousa J; Pais A
    Curr Pharm Des; 2015; 21(20):2698-712. PubMed ID: 25925125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-skin permeability relationships.
    Tsakovska I; Pajeva I; Al Sharif M; Alov P; Fioravanzo E; Kovarich S; Worth AP; Richarz AN; Yang C; Mostrag-Szlichtyng A; Cronin MTD
    Toxicology; 2017 Jul; 387():27-42. PubMed ID: 28645577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in predicting skin permeability of hydrophilic solutes.
    Chen L; Han L; Lian G
    Adv Drug Deliv Rev; 2013 Feb; 65(2):295-305. PubMed ID: 22580335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the suitability of chromatographic systems to predict human skin permeation of neutral compounds.
    Hidalgo-Rodríguez M; Soriano-Meseguer S; Fuguet E; Ràfols C; Rosés M
    Eur J Pharm Sci; 2013 Dec; 50(5):557-68. PubMed ID: 23602997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin permeation: the years of enlightenment.
    Hadgraft J; Lane ME
    Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation.
    Simon A; Amaro MI; Healy AM; Cabral LM; de Sousa VP
    Int J Pharm; 2016 Oct; 512(1):234-241. PubMed ID: 27568498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery.
    Khan NR; Harun MS; Nawaz A; Harjoh N; Wong TW
    Curr Pharm Des; 2015; 21(20):2848-66. PubMed ID: 25925113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(dimethylsiloxane): A Sustainable Human Skin Alternative for Transdermal Drug Delivery Prediction.
    Sabo S; Waters LJ
    J Pharm Sci; 2021 Mar; 110(3):1018-1024. PubMed ID: 33275991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and opportunities in dermal/transdermal delivery.
    Paudel KS; Milewski M; Swadley CL; Brogden NK; Ghosh P; Stinchcomb AL
    Ther Deliv; 2010 Jul; 1(1):109-31. PubMed ID: 21132122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of mathematical models for predicting skin permeability.
    Lian G; Chen L; Han L
    J Pharm Sci; 2008 Jan; 97(1):584-98. PubMed ID: 17722002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced skin permeability for transdermal drug delivery: physiopathological and physicochemical considerations.
    Xu P; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1991; 8(3):211-36. PubMed ID: 1954651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation.
    Geinoz S; Guy RH; Testa B; Carrupt PA
    Pharm Res; 2004 Jan; 21(1):83-92. PubMed ID: 14984261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic and empirical modeling of skin permeation of drugs.
    Yamashita F; Hashida M
    Adv Drug Deliv Rev; 2003 Sep; 55(9):1185-99. PubMed ID: 12954198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.